Bilaketaren emaitzak - Vahid Shaygannejad
- Erakusten 1 - 20 emaitzak -- 30
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
Clinical Characteristics and Disability Progression of Early- and Late-Onset Multiple Sclerosis Compared to Adult-Onset Multiple Sclerosis nork Omid Mirmosayyeb, Serge Brand, Mahdi Barzegar, Alireza Afshari-Safavi, Nasim Nehzat, Vahid Shaygannejad, Dena Sadeghi Bahmani
Argitaratua 2020Artigo -
12
-
13
In Patients With Multiple Sclerosis, Both Objective and Subjective Sleep, Depression, Fatigue, and Paresthesia Improved After 3 Weeks of Regular Exercise nork Dena Sadeghi Bahmani, J.P. Kesselring, Malamati Papadimitriou, Jens Bansi, Uwe Pühse, Markus Gerber, Vahid Shaygannejad, Edith Holsboer‐Trachsler, Serge Brand
Argitaratua 2019Artigo -
14
Multiple sclerosis and personality traits: associations with depression and anxiety nork Saeed Vaheb, Yousef Mokary, Mohammad Yazdan Panah, Aysa Shaygannejad, Alireza Afshari-Safavi, Majid Ghasemi, Vahid Shaygannejad, Elham Moases Ghaffary, Omid Mirmosayyeb
Argitaratua 2024Artigo -
15
Islamic fasting and multiple sclerosis nork Soodeh Razeghi Jahromi, Mohammad Ali Sahraian, Fereshteh Ashtari, Hormoz Ayromlou, Massoud Etemadifar, Majid Ghaffarpour, Ehsan Mohammadianinejad, Shahriar Nafissi, Alireza Nickseresht, Vahid Shaygannejad, Mansoureh Togha, Hamid Reza Torabi, Shadi Ziaie
Argitaratua 2014Revisão -
16
Comparative Effectiveness of Natalizumab, Fingolimod, and Injectable Therapies in Pediatric-Onset Multiple Sclerosis nork Tim Spelman, Gabrielle Simoneau, Robert Hyde, Robert Kuhelj, Raed Alroughani, Serkan Özakbaş, Rana Karabudak, Bassem Yamout, Samia J. Khoury, Murat Terzi, Cavit Boz, Dana Horáková, Eva Havrdová, Bianca Weinstock‐Guttman, Francesco Patti, Ayşe Altıntaş, Saloua Mrabet, Riadh Gouider, Jihad Inshasi, Vahid Shaygannejad, Sara Eichau, W. Luke Ward, Helmut Butzkueven
Argitaratua 2024Artigo -
17
Prognostic indicators in pediatric clinically isolated syndrome nork Pietro Iaffaldano, Marta Simone, Giuseppe Lucisano, Angelo Ghezzi, G. Coniglio, Vincenzo Brescia Morra, Giuseppe Salemi, Francesco Patti, Alessandra Lugaresi, Guillermo Izquierdo, Roberto Bergamaschi, José Antonio Cabrera-Gómez, Carlo Pozzilli, Enrico Millefiorini, Raed Alroughani, Cavit Boz, Eugenio Pucci, Giovanni Bosco Zimatore, Patrizia Sola, Giacomo Lus, Davide Maimone, Carlo Avolio, Eleonora Cocco, Seyed Aidin Sajedi, Gianfranco Costantino, Pierre Duquette, Vahid Shaygannejad, Thor Petersen, R. Fernandez Bolanos, Damiano Paolicelli, Carla Tortorella, Tim Spelman, Lucia Margari, Maria Pia Amato, Giancarlo Comi, Helmut Butzkueven, María Trojano
Argitaratua 2017Artigo -
18
Male Sex Is Independently Associated with Faster Disability Accumulation in Relapse-Onset MS but Not in Primary Progressive MS nork Karen Ribbons, Patrick McElduff, Cavit Boz, María Trojano, Guillermo Izquierdo, Pierre Duquette, Marc Girard, François Grand’Maison, Raymond Hupperts, Pierre Grammond, Celia Oreja‐Guevara, Thor Petersen, Roberto Bergamaschi, Giorgio Giuliani, Michael Barnett, Vincent Van Pesch, Maria Pia Amato, Gerardo Iuliano, Marcela Fiol, Mark Slee, Freek Verheul, Edgardo Cristiano, Ricardo Fernández‐Bolaños, Maria-Laura Saladino, Maria Edite Rio, José Antonio Cabrera-Gómez, Helmut Butzkueven, Erik van Munster, Leontien Den Braber‐Moerland, Daniele Spitaleri, Alessandra Lugaresi, Vahid Shaygannejad, Orla Gray, Norma Deri, Raed Alroughani, Jeannette Lechner‐Scott
Argitaratua 2015Artigo -
19
Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple Sclerosis nork J William L Brown, Alasdair Coles, Dana Horáková, Eva Havrdová, Guillermo Izquierdo, Alexandre Prat, Marc Girard, Pierre Duquette, María Trojano, Alessandra Lugaresi, Roberto Bergamaschi, Pierre Grammond, Raed Alroughani, Raymond Hupperts, Pamela McCombe, Vincent Van Pesch, Patrizia Sola, Diana Ferraro, François Grand’Maison, Murat Terzi, Jeannette Lechner‐Scott, S Flechter, Mark Slee, Vahid Shaygannejad, Eugenio Pucci, Franco Granella, Vilija Jokubaitis, Mark Willis, Claire M Rice, Neil Scolding, Alastair Wilkins, Owen Pearson, Tjalf Ziemssen, Michael Hutchinson, Katharine Harding, Joanne L. Jones, Christopher McGuigan, Helmut Butzkueven, Tomáš Kalinčík, Neil P. Robertson
Argitaratua 2019Artigo -
20
Comparison of fingolimod, dimethyl fumarate and teriflunomide for multiple sclerosis nork Tomáš Kalinčík, Eva Havrdová, Dana Horáková, Guillermo Izquierdo, Alexandre Prat, Marc Girard, Pierre Duquette, Pierre Grammond, Marco Onofrj, Alessandra Lugaresi, Serkan Özakbaş, Ludwig Kappos, Jens Kühle, Murat Terzi, Jeannette Lechner‐Scott, Cavit Boz, François Grand’Maison, Julie Prévost, Patrizia Sola, Diana Ferraro, Franco Granella, María Trojano, Roberto Bergamaschi, Eugenio Pucci, Recai Türkoğlu, Pamela McCombe, Vincent Van Pesch, Bart Van Wijmeersch, Claudio Solaro, Cristina Ramo‐Tello, Mark Slee, Raed Alroughani, Bassem Yamout, Vahid Shaygannejad, Daniele Spitaleri, José Luis Sánchez-Menoyo, Radek Ampapa, Suzanne Hodgkinson, Rana Karabudak, Ernest Butler, Steve Vucic, Vilija Jokubaitis, Tim Spelman, Helmut Butzkueven
Argitaratua 2019Artigo
Bilaketa egiteko lanabesak:
Antzeko gaiak
Medicine
Multiple sclerosis
Internal medicine
Immunology
Disease
Psychiatry
Pediatrics
Fingolimod
Physical therapy
Pathology
Natalizumab
Oncology
Alternative medicine
Cohort
Confidence interval
Coronavirus disease 2019 (COVID-19)
Discontinuation
Hazard ratio
Infectious disease (medical specialty)
Placebo
Proportional hazards model
Randomized controlled trial
Relapsing remitting
Anxiety
Clinical trial
Depression (economics)
Economics
Environmental health
Expanded Disability Status Scale
Intensive care medicine